(Reuters) – The $26,500-per-year price tag for Eisai Co Ltd and Biogen Inc’s newly approved Alzheimer’s disease drug is slightly…
Credit Suisse nears deal to buy Michael Klein’s advisory firm – Bloomberg News
(Reuters) – Credit Suisse Group AG is close to an agreement to acquire former Citigroup executive Michael Klein’s advisory boutique,…
Brazil’s soybean harvest off to slow start -AgRural
SAO PAULO (Reuters) – Harvesting of Brazil’s 2022/2023 soybean crop had reached 0.04% of the national planted area on Thursday…
AstraZeneca boosts heart, kidney business with $1.8 billion CinCor deal
By Natalie Grover (Reuters) -AstraZeneca said on Monday it had struck a deal to buy U.S.-based drug developer CinCor Pharma…
Moderna generates $18.4 billion in COVID vaccine sales in 2022
(Reuters) – Moderna Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022. (Reporting by…
Marketmind: Seeing through another shock
A look at the day ahead in U.S. and global markets from Mike Dolan. Brazil’s weekend political shock reminds world…
Carmaker Stellantis seals batteries material deal with Element 25
MILAN (Reuters) – Carmaker Stellantis has signed a deal with Australian miner Element 25 for the supply of manganese sulphite…
Berkshire Hathaway sells 1.1 million H-shares in China’s BYD
HONG KONG (Reuters) – Berkshire Hathaway, the investment company owned by Warren Buffett, has sold 1.058 million Hong Kong-listed shares…
U.S. Trustee files objection to FTX’s planned asset sales
(Reuters) – A U.S. Trustee filed an objection on Saturday to plans by bankrupt crypto exchange FTX to sell its…
Meta’s Oversight Board tells company to allow ‘death to Khamenei’ posts
By Katie Paul (Reuters) – Meta’s Oversight Board on Monday overturned the company’s decision to remove a Facebook post that…